We believe structural changes under new U.S. policies are setting the stage for the next leg of one of the greatest bull markets in history. The Clarity Act, the new FASB accounting rules effective in 2025, and the introduction of a 2.5% in-kind trade tax are catalysts that
The rise of cryptocurrency has rapidly moved from the fringes of finance into the very center of global capital markets. The launch of spot Bitcoin and Ethereum ETFs on U.S. exchanges such as the NYSE, Nasdaq, and CBOE has fundamentally changed how institutions, asset managers, and retail investors access
Modern farming has come to rely heavily on herbicides and fungicides, with glyphosate, marketed as Roundup, being the most widely used. The prevailing narrative is that the danger lies in chemical residues left on food, but the deeper and more insidious problem is what these chemicals do to the plants
The male fertility crisis is a growing, invisible epidemic that threatens future generations. While many people believe that the declining rates of reproduction are simply a lifestyle choice, an increasing number of people opting out of having children, the reality is far darker. The cause isn't a conscious
In February, I argued that 2025 would rhyme with 1926 — the year when a volatile, skeptical market finally launched into the vertical phase of one of history’s greatest bull runs. That view has only strengthened as the months pass. July landed close to my forecast of ~4% gains, with
Over the past two decades, rates of early-onset cancers have climbed at an alarming pace. Young adults under 50 are being diagnosed with colon, pancreatic, breast, and brain cancers at rates not seen in previous generations. While lifestyle changes and processed food consumption are frequently blamed, a growing body of
Non‑alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) have emerged as silent epidemics in the United States, affecting tens of millions of people, often without symptoms until advanced stages. These conditions do not develop in a vacuum. Instead, they are driven by a complex interplay between genetics,
In February, I wrote that 2025 would rhyme with 1926, the year when a volatile, skeptical market finally launched into the vertical phase of one of history’s greatest bull runs. By mid-year, that forecast has held: the spring correction shook out the weak hands, and U.S. equities have
Over the past two decades, breast cancer has surged in unexpected ways—particularly among young Asian American women. Once considered a lower-risk group, Asian American and Pacific Islander (AAPI) women are now seeing some of the fastest increases in breast cancer incidence in the United States. According to recent data,
Over the past 15 years, early-onset colorectal cancer (EOCRC), once a medical rarity, has exploded into a global public health crisis. Rates are climbing across nearly every major country, particularly among individuals aged 15 to 40. In fact, colorectal cancer is now on track to become the most diagnosed cancer
U.S. healthcare spending is on track to hit $7.7 trillion by 2032, a staggering and unsustainable figure. Yet emerging technologies in genetic stratification, remote biomarker monitoring, artificial intelligence, and targeted nutrition offer a potential paradigm shift. These tools offer a blueprint for cutting healthcare costs by as much
In today’s health care economy, there’s an uncomfortable truth that few want to say out loud: curing a patient is bad for business. The pharmaceutical industry, valued at over $1.5 trillion in 2023, is designed not to eliminate disease, but to manage it. Most new drugs approved